Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Declan T Chard

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
The Lancet. Neurology|August 21, 2021
Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a studyJ William L Brown, Nick G Cunniffe, Ferran Prados, et al.
Radiology|February 7, 2023
Multicenter Evaluation of AI-generated DIR and PSIR for Cortical and Juxtacortical Multiple Sclerosis Lesion DetectionPiet M Bouman, Samantha Noteboom, Fernando A Nobrega Santos, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 26, 2013
Brain atrophy and lesion load predict long term disability in multiple sclerosisVeronica Popescu, Federica Agosta, Hanneke E Hulst, et al.
Neurology|August 7, 2025
Effectiveness of Disease-Modifying Therapies in Patients With Late-Onset Relapsing-Remitting Multiple SclerosisSarmad Al-Araji, Marcello Moccia, Ashwani Jha, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
The Lancet. Neurology|August 21, 2021
Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a studyJ William L Brown, Nick G Cunniffe, Ferran Prados, et al.
Radiology|February 7, 2023
Multicenter Evaluation of AI-generated DIR and PSIR for Cortical and Juxtacortical Multiple Sclerosis Lesion DetectionPiet M Bouman, Samantha Noteboom, Fernando A Nobrega Santos, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 26, 2013
Brain atrophy and lesion load predict long term disability in multiple sclerosisVeronica Popescu, Federica Agosta, Hanneke E Hulst, et al.
Neurology|August 7, 2025
Effectiveness of Disease-Modifying Therapies in Patients With Late-Onset Relapsing-Remitting Multiple SclerosisSarmad Al-Araji, Marcello Moccia, Ashwani Jha, et al.
Pageof 8